Loading
  • Pipeline Pipeline
    • Pipeline Chart
    • uPAR-targeted radiopharmaceuticals
    • MNPR-101
      • Overview
      • Development Strategy
      • SNMMI Poster June 2024
      • EANM Presentation October 2024
    • Collaborations
      • Overview
      • Current Collaborations
    • Publications
      • MNPR-101
    • ALXN1840
  • Investors Investors
    • Overview
    • Annual Meeting
    • News / Events
      • Press Releases
      • IR Calendar
      • In the News
      • Email Alerts
    • Company Information
      • Profile
      • Presentations
      • Our Team
      • FAQ
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Corporate Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
  • Our Team Our Team
  • Contact Us Contact Us
  • Home
  • Pipeline
  • Publications
Pipeline

Pipeline

  • Pipeline Chart
  • uPAR-targeted radiopharmaceuticals
  • MNPR-101
    • Overview
    • Development Strategy
    • SNMMI Poster June 2024
    • EANM Presentation October 2024
  • Collaborations
    • Overview
    • Current Collaborations
  • Publications
  • ALXN1840

  • Publications

  • MNPR-101

Publications

  • About
  • Pipeline
  • Investors
  • Our Team
  • Contact Us
  • Pipeline
  • Pipeline Chart
  • uPAR-targeted radiopharmaceuticals
  • MNPR-101
  • Collaborations
  • Publications
  • ALXN1840
  • Investors
  • Overview
  • Annual Meeting
  • News / Events
  • Company Information
  • Stock Data
  • SEC Filings
  • Corporate Governance

Terms and Conditions of Use

© 2024 Monopar Therapeutics Inc. All Rights Reserved.